Fosphenytoin

In the US, Fosphenytoin (fosphenytoin systemic) is a member of the drug class hydantoin anticonvulsants and is used to treat Epilepsy and Status Epilepticus.

US matches:

• Fosphenytoin


• Fosphenytoin Injection


• Fosphenytoin Sodium

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N03AB05

CAS registry number (Chemical Abstracts Service)

0093390-81-9

Chemical Formula

C16-H15-N2-O6-P

Molecular Weight

362

Therapeutic Category

Antiepileptic agent

Chemical Name

2,4-Imidazolidinedione, 5,5-diphenyl-3-[(phosphonooxy)methyl]-

Foreign Names

• Fosphenytoinum (Latin)
• Fosphenytoin (German)
• Fosphenytoine (French)
• Fosfenitoina (Spanish)

Generic Names

• Fosphenytoin (OS: BAN)
• CI 982 (IS)
• Fosphenytoin Sodium (OS: BANM, USAN)
• ACC 9653 (IS)
• ACC 9653-010 (IS: Parke-Davis)
• PD 135711-15B (IS)
• Fosphenytion sodium (PH: USP 32)

Brand Names

• Cerebyx
  Pfizer, United States



• Fosphenytoin Sodium
  Akorn, United States; Apotex, United States; APP, United States; Baxter, United States; Bedford, United States; Hikma, United States; Hospira, United States; PharmaForce, United States; Sun, United States; Teva USA, United States; Wockhardt, United States



• Prodilantin
  Pfizer, France



• Pro-Epanutin
  Parke Davis, Ireland; Pfizer, Denmark; Pfizer, Finland; Pfizer, United Kingdom; Pfizer, Iceland; Pfizer, Norway; Pfizer, Sweden

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.